Molbio's proprietary test kits accounted for most product revenue in FY26, while unused manufacturing capacity offers room to ...

Under the proposed arrangement, the government plans to initially earmark one Truenat platform per district for viral load ...

Molbio rapidly developed a test on the Truenat platform and after validation by Indian Council of Medical Research (ICMR) was able to repurpose these devices to increase testing capacity pan India.

Truenat is rapidly evolving into a multi-disease, point-of-care diagnostic platform crucial for disease outbreak preparedness, informs Sriram Natarajan, founder and CEO of Molbio, while envisioning an ...

In the base case, Motilal Oswal has assigned a 45-times 12-month forward price-to-earnings multiple to Molbio Diagnostics, a 20% premium to its sector multiple of 36 times, citing the company's ...

Motilal Oswal initiated coverage on Molbio Diagnostics with a Buy rating and ₹1,800 target, implying 21% upside. The brokerage sees strong growth potential from decentralised molecular diagnostics, ...

In the recent years, Molbio Diagnostics’s Truenat technology has transformed the molecular diagnostics space in India. In an exclusive conversation with Financial Express.com, Sriram Natarajan, ...

For the first time, the city will use TrueNat Beta CoV as a final confirmatory test for Covid-19. On Tuesday, it received 90 kits that have the required confirmatory chips for the purpose.

The district health department is likely to start using TrueNat tests from Monday at the old civil hospital for conducting confirmatory tests on Covid-19 patients before discharging them from ...

World Health Organisation (WHO) has now endorsed three rapid molecular Truenat assays for initial diagnosis of tuberculosis (TB) and subsequent detection of rifampicin resistance in adults and ...

Verna: Molbio Diagnostics has launched a new test for differential diagnosis of HIV1/HIV2 with viral loads within 60 minutes. The test works on the existing Truelab infrastructure and will require no ...